Skip to content

Analysis of clinical and pathological characteristics of pelvic endometriosis during pregnancy and perimenopause

Analysis of clinical and pathological characteristics of pelvic endometriosis during pregnancy and perimenopause

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092112
Enrollment
Unknown
Registered
2024-11-11
Start date
2024-11-11
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

Pregnancy complicated with endometriosis group:None
Pregnancy complicated with other ovarian tumor group:None
Perimenopausal pelvic endometriosis with surgical treatment group:None
Perimenopausal pelvic endometriosis with follow up group:None

Sponsors

Obstetrics and Gynaecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Endometriosis during pregnancy: ? Experimental Group:Patients in early pregnancy (6-8 weeks of gestation) with clinical or imaging diagnosis (B-ultrasound and/or MRI) of endometriosis (including but not limited to OMA);? control group: Pregnant women with ovarian tumors diagnosed clinically or by imaging (B-ultrasound and/or MRI) Endometriosis during perimenopause: 40-55 years old, in perimenopause; 2. Clinical diagnosis or imaging diagnosis (B-ultrasound and/or MRI) of pelvic endometriosis (OMA or DE ± adenomyosis)

Exclusion criteria

Exclusion criteria: Endometriosis during pregnancy: ?experimental group: Suspected or confirmed malignant tumors before pregnancy; Choosing abortion for personal reasons during pregnancy; Those with contraindications to MRI examination; Pathological pregnancy (ectopic pregnancy, missed abortion, hydatidiform mole, etc.) ?control group: Ovarian endometrioid cyst suspected by imaging; No imaging report of ovarian tumor follow-up during pregnancy; No surgery and no pathological report during pregnancy to 1 year after delivery Endometriosis during perimenopause:1. History of previous malignant tumor; 2. History of previous LHBSO or bilateral oophorectomy; 3. Contraindications to MRI examination; 4. Postoperative pathology suggests only adenomyosis

Design outcomes

Primary

MeasureTime frame
The accuracy of imaging diagnosis of endometriosis (the consistency between MRI/ultrasound and pathological results);The rate of malignant transformation of pelvic endometriosis during perimenopause;

Secondary

MeasureTime frame
Endometriosis progression rate during pregnancy;pregnancy outcome;The incidence of maternal complications during pregnancy;The incidence of decidualization in endometriosis during pregnancy;

Countries

China

Contacts

Public ContactYi Xiaofang

Obstetrics and Gynaecology Hospital of Fudan University

yix@fudan.edu.cn+86 150 2658 5241

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026